Praecis Pharmaceuticals, Inc.

Farah Natoli

Malcolm L Gefter

Mark A Findeis

David I Israel

Ethan R Signer

Howard Benjamin

Michael Kelley

Arvind Hundal

Alicia Peticolas

Kuanghui Lu

Martin P Keough

William Goodwin

Ling Chai

This invention provides peptide compounds that bind to either a fibroblast growth factor (FGF) or a fibroblast growth factor receptor (FGFR) and, accordingly, are useful for modulating FGFR activity. Preferably, the FGFR is FGFR2-IIIC. Preferably, the FGF is basic FGF. Preferably the peptide compound comprises an amino acid sequence: (Y/F)-(L/F/I)-(R/D/E/S/Y/G)-(Q/L/Y)-Y-(M/L/K/R)-(L/M/D/E/N/S)-(R/L/S/T)-(L/F/M/V) (SEQ ID NO: 1). The invention further comprises pharmaceutical compositions comprising the peptide compounds of the invention and a pharmaceutically acceptable carrier. The invention still further provides methods of modulating FGFR activity using the peptide compounds of the invention.

Peptide compounds useful for modulating FGF receptor activity

Growing community of inventors

Quincy, MA, United States of America

Farah Natoli